FIELD: medicine.
SUBSTANCE: biological tissue is exposed successively in any sequence to optical light of the first range at wave lengths 950-970 nm, optical light of the second range at wave lengths 1020-1060 nm, optical light of the third range at wave lengths 930-950 nm, optical light of the fourth range at wave lengths 740-760 nm and optical light of the fifth range at wave lengths 830-850 nm. The optical light diffuse-reflected by the biological tissue is received and transformed into an electrical signal. The blood glucose concentration is determined with the use of an experimental calibration dependence of a glucose concentration and received resultant electrical signal having a value of URESULTANT = U2+U3+U5-U1(k12+k13+k15)-U4(k42+k43+k45), wherein U1, U2, U3, U4, U5 are the electrical signals received when exposing the biological tissue to the optical light of the first, second, third, fourth and fifth ranges, respectively; k12, k13, k15 are coefficients derived in keeping with the expressions k12 = K2S2/K1/S1, k13 = K3S3/K1/S1, k15 = K5S5/K1/S1, wherein K1, K2, K3, K5 are average water absorption factors in the first, second, third, fourth and fifth wave length ranges, respectively; S1, S2, S3, S5 are average relative spectral responses of an optical light receiver in the first, second, third, fourth and fifth wave length ranges, respectively; k42, k43, k45 are coefficient pre-derived in keeping with the expressions k42 = K2S2/K4/S4, k43 = K3S3/K4/S4, k45 = K5S5/K4/S4, wherein K2, K3, K4, K5 are average water absorption factors in the first, second, third, fourth and fifth wave length ranges, respectively; S2, S3, S4, S5 are average relative spectral responses of an optical light receiver in the second, third, fourth and fifth wave length ranges, respectively.
EFFECT: more accurate blood glucose concentration determination by reducing a measurement uncertainty caused by presence of water and melanin in the analysed biological tissue.
2 dwg
| Title | Year | Author | Number | 
|---|---|---|---|
| METHOD OF NONINVASIVE DETERMINATION OF BLOOD COMPONENT CONCENTRATIONS | 2016 | 
 | RU2645943C1 | 
| METHOD OF PROTECTING WOOD FROM INSECT PESTS AND DEVICE FOR ITS IMPLEMENTATION | 2018 | 
 | RU2696112C1 | 
| OPTICAL SENSOR OF SHORT-WAVE INFRARED SPECTRUM FOR BIOMEDICAL APPLICATIONS | 2024 | 
 | RU2839510C1 | 
| DEVICE FOR HUMAN CONDITION DETERMINATION | 2017 | 
 | RU2732211C1 | 
| METHOD FOR NON-INVASIVE DETERMINATION OF THE CONTENT OF WATER IN BLOOD AND BIOLOGICAL MEDIA | 2021 | 
 | RU2782327C1 | 
| BIOSENSOR FOR NON-INVASIVE OPTICAL MONITORING OF BIOLOGICAL TISSUES PATHOLOGY | 2016 | 
 | RU2633494C2 | 
| METHOD FOR DETERMINING OPTICAL AND BIOPHYSICAL TISSUE PARAMETERS | 2012 | 
 | RU2510506C2 | 
| DEVICE FOR SPECTROPHOTOMETRIC ASSESSMENT OF BLOOD FILLING LEVEL OF HUMAN TISSUES AND ORGANS SURFACE LAYERS IN VIVO | 2016 | 
 | RU2637102C1 | 
| METHOD OF NON-INVASIVE DETERMINATION OF BLOOD GLUCOSE CONCENTRATION | 2019 | 
 | RU2718258C1 | 
| DEVICE FOR MEASURING BLOOD GLUCOSE CONCENTRATION IN NONINVASIVE WAY | 2004 | 
 | RU2279250C2 | 
Authors
Dates
2016-02-10—Published
2014-12-22—Filed